| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
FIDSON Stock Overview
Fidson Healthcare Plc engages in the manufacture and distribution of pharmaceutical products in Nigeria.
Fidson Healthcare Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦8.85 |
| 52 Week High | ₦11.49 |
| 52 Week Low | ₦5.45 |
| Beta | 0.14 |
| 1 Month Change | -2.21% |
| 3 Month Change | -8.67% |
| 1 Year Change | 58.29% |
| 3 Year Change | 186.32% |
| 5 Year Change | 150.90% |
| Change since IPO | 209.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| FIDSON | NG Pharmaceuticals | NG Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | 1.0% |
| 1Y | 58.3% | 17.4% | 2.0% |
Return vs Industry: FIDSON exceeded the NG Pharmaceuticals industry which returned 17.4% over the past year.
Return vs Market: FIDSON exceeded the NG Market which returned 1.3% over the past year.
Price Volatility
| FIDSON volatility | |
|---|---|
| FIDSON Average Weekly Movement | 5.6% |
| Pharmaceuticals Industry Average Movement | 4.3% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in NG Market | 6.8% |
| 10% least volatile stocks in NG Market | 3.2% |
Stable Share Price: FIDSON is not significantly more volatile than the rest of NG stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: FIDSON's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 478 | Fidelis Ayebae | https://www.fidson.com |
Fidson Healthcare Plc engages in the manufacture and distribution of pharmaceutical products in Nigeria. The company operates through three segments: Over-the-Counter, Ethical Products, and Consumer. It offers drugs, injectables, and infusions.
Fidson Healthcare Plc Fundamentals Summary
| FIDSON fundamental statistics | |
|---|---|
| Market Cap | ₦20.31b |
| Earnings (TTM) | ₦4.84b |
| Revenue (TTM) | ₦40.49b |
4.2x
P/E Ratio0.5x
P/S RatioIs FIDSON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FIDSON income statement (TTM) | |
|---|---|
| Revenue | ₦40.49b |
| Cost of Revenue | ₦22.08b |
| Gross Profit | ₦18.41b |
| Other Expenses | ₦13.57b |
| Earnings | ₦4.84b |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.11 |
| Gross Margin | 45.47% |
| Net Profit Margin | 11.94% |
| Debt/Equity Ratio | 97.5% |
How did FIDSON perform over the long term?
See historical performance and comparison